Predictors of cost-effectiveness of selected COPD treatments in primary care: UNLOCK study protocol

Affiliations

¹ Unit of PharmacoEpidemiology and PharmacoEconomics (PE2), Department of Pharmacy, University of Groningen, Groningen, The Netherlands.
² Institituto de Investigacíon Sanitaria de Palma (IdISPa), Palma de Mallorca, Spain.
³ Department of General Practice, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
⁴ Instituto de Investigación Hospital Universitario de la Princesa (IISP), Universidad Autónonoma de Madrid, Cátedra UAM-Linde, Madrid, Spain.
⁵ 1] Unit of PharmacoEpidemiology and PharmacoEconomics (PE2), Department of Pharmacy, University of Groningen, Groningen, The Netherlands [2] Institute of Science in Healthy Aging and HealthcaRE (SHARE), University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.

Observational Study

Job F M van Boven et al. NPJ Prim Care Respir Med. 2015.

. 2015 Aug 6:25:15051.

doi: 10.1038/npjpcrm.2015.51.

¹ Unit of PharmacoEpidemiology and PharmacoEconomics (PE2), Department of Pharmacy, University of Groningen, Groningen, The Netherlands.
² Institituto de Investigacíon Sanitaria de Palma (IdISPa), Palma de Mallorca, Spain.
³ Department of General Practice, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
⁴ Instituto de Investigación Hospital Universitario de la Princesa (IISP), Universidad Autónonoma de Madrid, Cátedra UAM-Linde, Madrid, Spain.
⁵ 1] Unit of PharmacoEpidemiology and PharmacoEconomics (PE2), Department of Pharmacy, University of Groningen, Groningen, The Netherlands [2] Institute of Science in Healthy Aging and HealthcaRE (SHARE), University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.

No abstract available

References

1. World Health Organization Chronic obstructive pulmonary disease . Available at http://www.who.int/respiratory/copd/en/ . Accessed 22 February 2015.
1. van Boven JF, Vegter S, van der Molen T, Postma MJ. COPD in the working age population: the economic impact on both patients and government. COPD. 2013;10:629–639. - PubMed
1. Lababidi H, Abu-Shaheen AK, Bou Mehdi IA, Al-Tannir MA. Asthma care practicing among general practitioners in Lebanon: a cross-sectional study. J Asthma. 2014;51:51–57. - PMC - PubMed
1. de Miguel-Diez J, Carrasco-Garrido P, Rejas-Gutierrez J, Martin-Centeno A, Gobartt-Vazquez E, Hernandez-Barrera V. Inappropriate overuse of inhaled corticosteroids for COPD patients: impact on health costs and health status. Lung. 2011;189:199–206. - PubMed
1. Pozo-Rodriguez F, Lopez-Campos JL, Alvarez-Martinez CJ, Castro-Acosta A, Aguero R, Hueto J. Clinical audit of COPD patients requiring hospital admissions in Spain: AUDIPOC study. PLoS One. 2012;7:e42156. - PMC - PubMed